Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[SRSF2 and U2AF1 along with TET2 (48%) and ASXL1 (38%) are frequently affected by somatic mutations in chronic myelomonocytic leukemia, quite distinctly from the profile seen in juvenile myelomonocytic leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP913984.RATXHv9KYBdwwr4ySAcXdmSMOUj1KIJJlEct-LmiFW62A130_assertion description "[SRSF2 and U2AF1 along with TET2 (48%) and ASXL1 (38%) are frequently affected by somatic mutations in chronic myelomonocytic leukemia, quite distinctly from the profile seen in juvenile myelomonocytic leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP913984.RATXHv9KYBdwwr4ySAcXdmSMOUj1KIJJlEct-LmiFW62A130_provenance.
• assertion description "[SRSF2 and U2AF1 along with TET2 (48%) and ASXL1 (38%) are frequently affected by somatic mutations in chronic myelomonocytic leukemia, quite distinctly from the profile seen in juvenile myelomonocytic leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[SRSF2 and U2AF1 along with TET2 (48%) and ASXL1 (38%) are frequently affected by somatic mutations in chronic myelomonocytic leukemia, quite distinctly from the profile seen in juvenile myelomonocytic leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[SRSF2 and U2AF1 along with TET2 (48%) and ASXL1 (38%) are frequently affected by somatic mutations in chronic myelomonocytic leukemia, quite distinctly from the profile seen in juvenile myelomonocytic leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[SRSF2 and U2AF1 along with TET2 (48%) and ASXL1 (38%) are frequently affected by somatic mutations in chronic myelomonocytic leukemia, quite distinctly from the profile seen in juvenile myelomonocytic leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[SRSF2 and U2AF1 along with TET2 (48%) and ASXL1 (38%) are frequently affected by somatic mutations in chronic myelomonocytic leukemia, quite distinctly from the profile seen in juvenile myelomonocytic leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[SRSF2 and U2AF1 along with TET2 (48%) and ASXL1 (38%) are frequently affected by somatic mutations in chronic myelomonocytic leukemia, quite distinctly from the profile seen in juvenile myelomonocytic leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP764453.RAqD71Njz-rhE6wjgWginXpQemTQ52bzlTZxJOnf6SbdQ130_assertion description "[SRSF2 and U2AF1 along with TET2 (48%) and ASXL1 (38%) are frequently affected by somatic mutations in chronic myelomonocytic leukemia, quite distinctly from the profile seen in juvenile myelomonocytic leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP764453.RAqD71Njz-rhE6wjgWginXpQemTQ52bzlTZxJOnf6SbdQ130_provenance.
• NP996062.RAefBp3sGzS21jZB8gCEYW-QopVYuuCFDQuMcI6iZxleM130_assertion description "[SRSF2 and U2AF1 along with TET2 (48%) and ASXL1 (38%) are frequently affected by somatic mutations in chronic myelomonocytic leukemia, quite distinctly from the profile seen in juvenile myelomonocytic leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP996062.RAefBp3sGzS21jZB8gCEYW-QopVYuuCFDQuMcI6iZxleM130_provenance.
• NP996065.RAYfueBKBZekD2vs7FjVBWWGfoyjjiOA93R-DAz8b4fSY130_assertion description "[SRSF2 and U2AF1 along with TET2 (48%) and ASXL1 (38%) are frequently affected by somatic mutations in chronic myelomonocytic leukemia, quite distinctly from the profile seen in juvenile myelomonocytic leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP996065.RAYfueBKBZekD2vs7FjVBWWGfoyjjiOA93R-DAz8b4fSY130_provenance.
• NP996068.RAQf_XXHnBkiniI5ejytdi6SLeYkMIdCmL7d3qxSapFNk130_assertion description "[SRSF2 and U2AF1 along with TET2 (48%) and ASXL1 (38%) are frequently affected by somatic mutations in chronic myelomonocytic leukemia, quite distinctly from the profile seen in juvenile myelomonocytic leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP996068.RAQf_XXHnBkiniI5ejytdi6SLeYkMIdCmL7d3qxSapFNk130_provenance.
• NP996069.RAfY2CFUQHpFP28ItFa2W-OdTgXyrLhOHT8IA2P26SuWg130_assertion description "[SRSF2 and U2AF1 along with TET2 (48%) and ASXL1 (38%) are frequently affected by somatic mutations in chronic myelomonocytic leukemia, quite distinctly from the profile seen in juvenile myelomonocytic leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP996069.RAfY2CFUQHpFP28ItFa2W-OdTgXyrLhOHT8IA2P26SuWg130_provenance.
• NP996071.RAWZxm-B32HSQpdEcBBDQZO13Cr5sEFP_e4vLXrxQ5UnY130_assertion description "[SRSF2 and U2AF1 along with TET2 (48%) and ASXL1 (38%) are frequently affected by somatic mutations in chronic myelomonocytic leukemia, quite distinctly from the profile seen in juvenile myelomonocytic leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP996071.RAWZxm-B32HSQpdEcBBDQZO13Cr5sEFP_e4vLXrxQ5UnY130_provenance.
• NP691395.RAj4d0FsOStZLUQaWvJLic_7kxNknX3Htc_3lCUMxOoxY130_assertion description "[SRSF2 and U2AF1 along with TET2 (48%) and ASXL1 (38%) are frequently affected by somatic mutations in chronic myelomonocytic leukemia, quite distinctly from the profile seen in juvenile myelomonocytic leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP691395.RAj4d0FsOStZLUQaWvJLic_7kxNknX3Htc_3lCUMxOoxY130_provenance.
• assertion description "[SRSF2 and U2AF1 along with TET2 (48%) and ASXL1 (38%) are frequently affected by somatic mutations in chronic myelomonocytic leukemia, quite distinctly from the profile seen in juvenile myelomonocytic leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[SRSF2 and U2AF1 along with TET2 (48%) and ASXL1 (38%) are frequently affected by somatic mutations in chronic myelomonocytic leukemia, quite distinctly from the profile seen in juvenile myelomonocytic leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP914144.RAC0j0ziKQpNZNLvF1E38QczOCww9e6wP4CZ_BmaoXgpk130_assertion description "[SRSF2 and U2AF1 along with TET2 (48%) and ASXL1 (38%) are frequently affected by somatic mutations in chronic myelomonocytic leukemia, quite distinctly from the profile seen in juvenile myelomonocytic leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP914144.RAC0j0ziKQpNZNLvF1E38QczOCww9e6wP4CZ_BmaoXgpk130_provenance.
• NP978488.RAjPGsb4pDEM54EZMscGRysW54RAoPIz497P6HYylH5Pk130_assertion description "[SRSF2 and U2AF1 along with TET2 (48%) and ASXL1 (38%) are frequently affected by somatic mutations in chronic myelomonocytic leukemia, quite distinctly from the profile seen in juvenile myelomonocytic leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP978488.RAjPGsb4pDEM54EZMscGRysW54RAoPIz497P6HYylH5Pk130_provenance.
• NP978624.RArGUo4Q3OBiPCA4MA3R4fVlFVGYhZyfZ4GdZiEad2Tb4130_assertion description "[SRSF2 and U2AF1 along with TET2 (48%) and ASXL1 (38%) are frequently affected by somatic mutations in chronic myelomonocytic leukemia, quite distinctly from the profile seen in juvenile myelomonocytic leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP978624.RArGUo4Q3OBiPCA4MA3R4fVlFVGYhZyfZ4GdZiEad2Tb4130_provenance.
• NP996063.RAiG-ZGcupFAnf1zREU_fg6BBnQgwO2mlYnvfOxbMW8-g130_assertion description "[SRSF2 and U2AF1 along with TET2 (48%) and ASXL1 (38%) are frequently affected by somatic mutations in chronic myelomonocytic leukemia, quite distinctly from the profile seen in juvenile myelomonocytic leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP996063.RAiG-ZGcupFAnf1zREU_fg6BBnQgwO2mlYnvfOxbMW8-g130_provenance.
• NP1018505.RAN_CcagJ6C8x9odTCauJkqLMVHYPyD369o9RS4XWHUQQ130_assertion description "[SRSF2 and U2AF1 along with TET2 (48%) and ASXL1 (38%) are frequently affected by somatic mutations in chronic myelomonocytic leukemia, quite distinctly from the profile seen in juvenile myelomonocytic leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1018505.RAN_CcagJ6C8x9odTCauJkqLMVHYPyD369o9RS4XWHUQQ130_provenance.
• NP1018524.RAHCxPtWqPf4A2RGsVMQNMmeDJYn2U_VTiL44YNku0zhw130_assertion description "[SRSF2 and U2AF1 along with TET2 (48%) and ASXL1 (38%) are frequently affected by somatic mutations in chronic myelomonocytic leukemia, quite distinctly from the profile seen in juvenile myelomonocytic leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1018524.RAHCxPtWqPf4A2RGsVMQNMmeDJYn2U_VTiL44YNku0zhw130_provenance.
• NP691434.RAJ3_-V_WYT4c9-ZG0A9GZtSEo7C5vb0URLHrny274gkA130_assertion description "[SRSF2 and U2AF1 along with TET2 (48%) and ASXL1 (38%) are frequently affected by somatic mutations in chronic myelomonocytic leukemia, quite distinctly from the profile seen in juvenile myelomonocytic leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP691434.RAJ3_-V_WYT4c9-ZG0A9GZtSEo7C5vb0URLHrny274gkA130_provenance.
• NP764472.RAOKY1XXna2P9KAV2wIWVdDNF_Sa09e5Zs4HzYNPqfs20130_assertion description "[SRSF2 and U2AF1 along with TET2 (48%) and ASXL1 (38%) are frequently affected by somatic mutations in chronic myelomonocytic leukemia, quite distinctly from the profile seen in juvenile myelomonocytic leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP764472.RAOKY1XXna2P9KAV2wIWVdDNF_Sa09e5Zs4HzYNPqfs20130_provenance.
• NP996061.RAPpkaVTO1vUf5YgdlzcUjgh61Z87Tpi6VEAMYIs_Wyqc130_assertion description "[SRSF2 and U2AF1 along with TET2 (48%) and ASXL1 (38%) are frequently affected by somatic mutations in chronic myelomonocytic leukemia, quite distinctly from the profile seen in juvenile myelomonocytic leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP996061.RAPpkaVTO1vUf5YgdlzcUjgh61Z87Tpi6VEAMYIs_Wyqc130_provenance.
• NP996067.RAESFQe_ZEEa03vHF6665o-PR1j0y8D5wIL8bzNF-LhSg130_assertion description "[SRSF2 and U2AF1 along with TET2 (48%) and ASXL1 (38%) are frequently affected by somatic mutations in chronic myelomonocytic leukemia, quite distinctly from the profile seen in juvenile myelomonocytic leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP996067.RAESFQe_ZEEa03vHF6665o-PR1j0y8D5wIL8bzNF-LhSg130_provenance.
• NP996064.RA1WFjL8U1i8Q8CDqdg8S-h2COaZBA3blFc5MvKw4O7SE130_assertion description "[SRSF2 and U2AF1 along with TET2 (48%) and ASXL1 (38%) are frequently affected by somatic mutations in chronic myelomonocytic leukemia, quite distinctly from the profile seen in juvenile myelomonocytic leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP996064.RA1WFjL8U1i8Q8CDqdg8S-h2COaZBA3blFc5MvKw4O7SE130_provenance.
• NP996070.RA56ORS_9UIxnR8FgxBceZxPYfwPl4UiIdyTj1FF2Dto8130_assertion description "[SRSF2 and U2AF1 along with TET2 (48%) and ASXL1 (38%) are frequently affected by somatic mutations in chronic myelomonocytic leukemia, quite distinctly from the profile seen in juvenile myelomonocytic leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP996070.RA56ORS_9UIxnR8FgxBceZxPYfwPl4UiIdyTj1FF2Dto8130_provenance.